ProPhase Labs rises on share buyback plan
** Shares of drug manufacturer PRPH.O up ~1% at $5.3
** Co's board authorizes repurchase of up to $6 mln PRPH
shares urn:newsml:reuters.com:*:nGNX2FG5vp
** Co engages ThinkEquity to facilitate the share repurchase
program
** Under the program, co may repurchase its common stock
over the next six months
** Stock down ~40% YTD
(Reporting by Sahil Shaw in Bengaluru)
((sahil.shaw@thomsonreuters.com))
Recent news on Prophase Labs
See all newsBrief: Prophase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 08:29 PM